Masonic Cancer Center, University of Minnesota: Lung Neoplasms trials
The registry lists 12 Lung Neoplasms studies with Masonic Cancer Center, University of Minnesota as lead sponsor. 1 are open to participants now and 3 have results posted.
Phase 1 5Phase 2 7No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II TrialRecruitingNCT04105270Phase 2
- Exemestane in Post-Menopausal Women With NSCLCCompletedNCT02666105Phase 2Results posted
- Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic ChemotherapyCompletedNCT00365547Phase 2Results posted
- Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung CancerTerminatedNCT00281827Phase 2Results posted
- Charcoal in Lung Cancer Patients Undergoing TEMLAWithdrawnNCT04928950Phase 2
- Metabolism of NNK Among African AmericansCompletedNCT01158456
- Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone MetastasesWithdrawnNCT00769990Phase 1/2
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung CancerWithdrawnNCT00748163Phase 2
- Bortezomib and Cetuximab in Treating Patients With Advanced Solid TumorsCompletedNCT00622674Phase 1
- Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid TumorsCompletedNCT00620295Phase 1
- Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lung CancerTerminatedNCT00619021Phase 1
- Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLCTerminatedNCT00356941Phase 1